Secret Vaccine Meeting: NIH Locks Doors on Adjuvant Deals
Published Date: 3/19/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 3-4, 2025, to review secret contract proposals for developing vaccine adjuvants. This affects small businesses competing for government research contracts and keeps sensitive info private. The meeting helps decide who gets funding to boost vaccine innovation, with no public access to protect trade secrets and personal data.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 1 costs, 1 mixed.
Closed Review Protects Trade Secrets
If you are a small business submitting an SBIR contract proposal for adjuvant development (Solicitation PHS 2025-1, NIH/NIAID 142), the review on April 3-4, 2025 will be closed and your confidential trade secrets and personal data will be kept private under 5 U.S.C. 552b(c)(4) and 552b(c)(6).
SBIR Award Decisions for Vaccine Adjuvants
On April 3-4, 2025, the NIAID Special Emphasis Panel will review and evaluate SBIR contract proposals under Solicitation PHS 2025-1 (NIH/NIAID 142) to decide which small businesses receive contracts for adjuvant development for vaccines.
Meeting Closed — No Public Access
The meeting on April 3-4, 2025 will be closed to the public, with no public access to the contract proposals or discussions, in order to protect trade secrets and personal information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-04466 — Notice of Inventory Completion: U.S. Department of Agriculture, Forest Service, Deschutes National Forest, Bend, OR
The Deschutes National Forest finished checking its collection of Native American human remains and related items. They found a clear connection to certain Indian Tribes and Native Hawaiian groups. This means these items will be returned to the right communities, following important laws, with no cost or delays expected.
Next: 2025-04468 — National Institute of Mental Health; Notice of Closed Meetings
The National Institute of Mental Health is holding two secret virtual meetings in April and May 2025 to review grant applications. These closed sessions protect private info and trade secrets while deciding who gets funding for mental health research. If you’re applying for grants, keep an eye on these dates—they’re key to the money decisions coming soon!